Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro
Everolimus (EVE), a mammalian target of rapamycin inhibitor, has been proposed as liver transplant immunosuppressive drug, gaining wide interest also for the treatment of cancer. Although an appropriate tolera...